Moise Danielpour

Title: Moise Danielpour: Innovator in Medical Treatments

Introduction

Moise Danielpour is a prominent inventor based in Los Angeles, CA. He has made significant contributions to the field of medical treatments, particularly in the area of growth disorders. With a total of 3 patents, his work focuses on innovative methods to address health challenges.

Latest Patents

One of his latest patents is titled "Use of FGFR inhibitors for treatment of idiopathic short stature." This invention describes methods for treating idiopathic short stature by administering an effective amount of a pan FGFR inhibitor or a selective FGFR inhibitor to the subject. An example of an FGFR inhibitor used in this method is erdafitinib. Another notable patent is "Systems and methods for in vivo dual recombinase-mediated cassette exchange (dRMCE) and disease models thereof." This patent outlines donor vectors and systems for in vivo dual recombinase-mediated cassette exchange, along with animal models for rigorous investigation of transgene expression.

Career Highlights

Throughout his career, Moise Danielpour has worked with esteemed institutions such as Cedars-Sinai Medical Center and Children's Hospital Medical Center. His experience in these organizations has allowed him to develop and refine his innovative approaches to medical treatments.

Collaborations

Moise has collaborated with notable colleagues, including Joshua Breunig and Gi Bum Kim. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Moise Danielpour is a dedicated inventor whose work in medical treatments has the potential to significantly impact the lives of individuals with growth disorders. His innovative patents and collaborations highlight his commitment to advancing healthcare solutions.